A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.

Also called NCT02853630

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 203 participants (enrolled count) (from the registry)
Sponsor
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals (from the registry)
Registry
  • NCT NCT02853630
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02853630. Randomized; no masking; primary purpose treatment. Start 2013-12 (actual); primary completion 2017-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
Condition
TYpe 2 Diabetes Mellitus
Intervention (Drug)
Metformin
Intervention (Drug)
Vildagliptin
Lead sponsor
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals (class: other)

Record details

Record id
cardio:ct-nct02853630
Content hash
b6b4d4d223206318adb74f5c2ed3f56b7a3d586eecea442c07a5cd52f5ea44e9